DrugPatentWatch Database Preview
Drugs in Development Information for Fasudil
Email this page to a colleague
» See Plans and PricingWhat is the development status for investigational drug Fasudil?
Fasudil is an investigational drug.
There have been 10 clinical trials for Fasudil.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2010.
The most common disease conditions in clinical trials are Motor Neuron Disease, Amyotrophic Lateral Sclerosis, and ST Elevation Myocardial Infarction. The leading clinical trial sponsors are Brigham and Women's Hospital, Shahid Beheshti University of Medical Sciences, and Doris Duke Charitable Foundation.
Summary for Fasudil
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,709 |
| WIPO Patent Applications | 1,294 |
| Japanese Patent Applications | 6 |
| Clinical Trial Progress | Phase 3 (2010-02-01) |
| Vendors | 56 |
Recent Clinical Trials for Fasudil
| Title | Sponsor | Phase |
|---|---|---|
| Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction | RenJi Hospital | Phase 4 |
| Fasudil Eye Drop in Retinopathy Of Prematurity(ROP) | Shahid Beheshti University of Medical Sciences | Phase 2/Phase 3 |
| Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS | University Medical Center Goettingen | Phase 2 |
Clinical Trial Summary for Fasudil
Top disease conditions for Fasudil
Top clinical trial sponsors for Fasudil
US Patents for Fasudil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
